FindTrial
Sign In

NUTRACEUTICALS AMONG TYPE 2 DIABETES MELLITUS

A STUDY ON PRESCRIPTION PATTERNS AND COST OF NUTRACEUTICALS AMONG TYPE 2 DIABETES MELLITUS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036684
Enrollment
150
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender above 18 years. 2. Both outpatients and inpatients department of general medicine diagnosed with Type 2 DM and prescribed with at least one nutraceutical.

Exclusion criteria

Exclusion criteria: 1. Pregnant women. (gestational diabetes) 2. Type 1 DM patients. 3. Patients who are not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
This study will find out the prescription pattern of nutraceuticals, and health care providers can get an idea regarding the most commonly utilized nutraceuticals among the in Type 2 DM patientsTimepoint: Baseline Assessment—

Secondary

MeasureTime frame
Assessment of cost of nutraceuticals per prescription among diabetic patients.Timepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Aditi K

NGSM institute of pharmaceutical sciences, Nitte (Deemed to be university)

udayvenkatmateti@gmail.com8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026